Rajiv Tayal
Interventional Cardiology · Fredericksburg, VANPI 1134457898
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 42 manufacturers reported payments, led by Abiomed at 56.4% of the total. Among interventional cardiology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,372 payments — averaging $716.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$555K
- Edwards Lifesciences$162K
- Medtronic$153K
- Shockwave Medical, Inc$89K
- Abbott$10K
- Cardiovascular Systems Inc.$3K
- plus $11K from 36 others
Across 75 payments — averaging $13,133 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cathworks, Inc.$555K
- Edwards Lifesciences$306K
- Medtronic$92K
- Boston Scientific$18K
- Essential Medical, Inc.$12K
- Arrow International, Inc.$2K
- plus $342 from 1 others
What the payments were for
- Consulting fees$172,47518%
- Speaking & faculty fees$564,64457%
- Travel & lodging$204,79421%
- Food & beverage$41,5444%
- Education$170%
- Entertainment$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 495 | $554,619 |
| Edwards Lifesciences | 332 | $161,901 |
| Medtronic(2 entities) | 252 | $152,794 |
| Shockwave Medical, Inc | 56 | $89,470 |
| Abbott | 61 | $10,224 |
| Cardiovascular Systems Inc. | 31 | $3,124 |
| Magenta Medical Inc | 2 | $3,000 |
| Boston Scientific | 27 | $2,700 |
| Opsens Inc. | 9 | $1,553 |
| Cathworks, Inc. | 2 | $412 |
| Acist Medical Systems, Inc. | 3 | $357 |
| Amgen | 24 | $352 |
| Novartis | 19 | $324 |
| Cardiva Medical, Inc. | 3 | $306 |
| Inari Medical, Inc. | 4 | $301 |
| Penumbra, Inc. | 4 | $237 |
| Cordis US CORP. | 2 | $228 |
| Saranas, Inc. | 3 | $170 |
| Recor Medical Inc | 1 | $151 |
| Surmodics, Inc. | 1 | $136 |
| Philips North America LLC | 1 | $134 |
| Asahi Intecc USA, Inc. | 1 | $119 |
| Reflow Medical Inc | 1 | $108 |
| AstraZeneca | 8 | $106 |
| Novo Nordisk | 5 | $103 |
| Heartflow, Inc. | 5 | $90 |
| Angiodynamics, Inc. | 1 | $87 |
| Endologix LLC | 1 | $61 |
| Biosense Webster, Inc. | 2 | $40 |
| Spectrawave, Inc | 1 | $36 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $31 |
| Vital Connect, Inc | 1 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Pfizer | 2 | $29 |
| Atricure, Inc. | 1 | $27 |
| Imperative Care, Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| Stryker | 1 | $19 |
| Terumo Medical Corporation | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
| Irhythm Technologies, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$507,892
- Edwards SAPIEN 3 Transcatheter Heart Valve$140,344
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$62,310
- COREVALVE EVOLUT R$48,792
- Vascular Lithotripsy$26,267
- FFRangio$23,305
- SYMPLICITY G3$7,616
- Perclose ProGlide suture mediated closure system$3,500
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$2,487
- Diamondback Coronary$2,463
- Omnilink Elite vascular stent system$2,250
- CoreValve Evolut$1,438
- EVOQUE$1,302
- GENERAL - THERAPIES$1,301
- SAPIEN 3 Ultra RESILIA$1,300
- ONYX FRONTIER$1,061
- SavvyWire$900
- Perclose ProStyle$755
- Diamondback Peripheral$572
- OptoWire$505
How this compares
$983,513 in reported general payments places this provider in the 95th percentile of 176 interventional cardiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 51 | $61,879 |
| BrilintaTicagrelor | 25 | $30,374 |
| EntrestoSacubitril/Valsartan | 15 | $17,908 |
| Praluent PenAlirocumab | 18 | $15,961 |
| Repatha SureclickEvolocumab | 17 | $13,589 |
| Metoprolol Succinate | 120 | $1,663 |
| ClopidogrelClopidogrel Bisulfate | 96 | $1,337 |
| Rosuvastatin Calcium | 66 | $1,169 |
| Atorvastatin Calcium | 103 | $925 |
| Amlodipine Besylate | 45 | $501 |
| Ezetimibe | 11 | $498 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $417 |
| Carvedilol | 25 | $347 |
| Potassium Chloride | 19 | $341 |
| Losartan Potassium | 32 | $294 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $29 | $61,87951 claims |
| AstraZenecaBrilinta | $106 | $30,37425 claims |
| NovartisEntresto | $324 | $17,90815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 176 interventional cardiology providers in Virginia.
Other interventional cardiology in Fredericksburg
- Thomas MartyakFredericksburg$66K
- Zeshan RanaFredericksburg$23K
- Clarence FindleyFredericksburg$19K
- Arijit ChandaFredericksburg$11K
- Deepak TalrejaVirginia Beach$1.5M
- Gansevoort DunningtonRichmond$440K
- Matthew SummersNorfolk$308K
- Noah JonesFalls Church$238K
- Michael GenVirginia Beach$207K
- Jeremy BockLeesburg$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.